Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vetnostrum Animal Health CoTPE:6936 +0.78%69 Debt-to-EBITDA is 0.08 as of Mar. 2026, which is 92% below its 10-year median of 0.96. GuruFocus rates TPE:6936 with a GF Score™ of 69/100 and a GF Value™ of NT$39.28 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,554 Consumer Packaged Goods companies, Vetnostrum Animal Health Co ranks better than 92.92% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Vetnostrum Animal Health Co's Debt-to-EBITDA or its related term are showing as below:
TPE:6936'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.09 Med: 0.96 Max: 1.48
Current: 0.09
During the past 8 years, the highest Debt-to-EBITDA Ratio of Vetnostrum Animal Health Co was 1.48. The lowest was 0.09. And the median was 0.96.
TPE:6936's Debt-to-EBITDA is ranked better than 92.92% of 1554
companies
in the Consumer Packaged Goods industry
Industry Median: 2.12
vs TPE:6936: 0.09
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Vetnostrum Animal Health Co Debt-to-EBITDA Related Terms
Vetnostrum Animal Health Co Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6936 vs ADM, BG, TSN: Debt-to-EBITDA Comparison
For the Farm Products subindustry, Vetnostrum Animal Health Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vetnostrum Animal Health Co Debt-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Vetnostrum Animal Health Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Vetnostrum Animal Health Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Vetnostrum Animal Health Co (TPE:6936) has a Debt-to-EBITDA of 0.08 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vetnostrum Animal Health Co. This is 92% below median its historical median of 0.96. Over the past decade, Vetnostrum Animal Health Co's Debt-to-EBITDA has ranged from 0.09 to 1.48. According to the industry distribution chart, Vetnostrum Animal Health Co ranks #110 out of 1554 companies in the Consumer Packaged Goods industry, placing it in the top 7.1%.
Is Vetnostrum Animal Health Co's Debt-to-EBITDA too high?
Vetnostrum Animal Health Co's current Debt-to-EBITDA of 0.08 is 92% below median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 1.48. The Consumer Packaged Goods industry median Debt-to-EBITDA is 2.12. Vetnostrum Animal Health Co's value of 0.08 is 96.2% below this industry median. Based on the distribution chart, Vetnostrum Animal Health Co ranks #110 out of 1554 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Vetnostrum Animal Health Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetnostrum Animal Health Co's Debt-to-EBITDA compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Vetnostrum Animal Health Co ranks #110 out of 1554 companies for Debt-to-EBITDA. This places Vetnostrum Animal Health Co in the top 7% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.12. Vetnostrum Animal Health Co's value of 0.08 is 96.2% below this benchmark. Historically, Vetnostrum Animal Health Co's own Debt-to-EBITDA has ranged from 0.09 to 1.48 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 2.12, Vetnostrum Animal Health Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.12, based on 1,554 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vetnostrum Animal Health Co's current Debt-to-EBITDA of 0.08 is 96.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Vetnostrum Animal Health Co. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vetnostrum Animal Health Co's current Debt-to-EBITDA is 0.08, which is 92% below median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetnostrum Animal Health Co stock overvalued right now?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co (TPE:6936) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$39.28, compared to a current price of NT$32.30 — trading 17.8% below its estimated fair value. The current Debt-to-EBITDA is 0.08, which is 92% below median its 10-year median of 0.96 and 96.2% below the Consumer Packaged Goods industry median of 2.12. Vetnostrum Animal Health Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Vetnostrum Animal Health Co (TPE:6936), the current Debt-to-EBITDA is 0.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vetnostrum Animal Health Co (TPE:6936) Overvalued in 2026?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co stock appears to be undervalued.
The current stock price of NT$32.30 is trading 17.8% below its estimated GF Value™ of NT$39.28.
GuruFocus considers Vetnostrum Animal Health Co to be Modestly Undervalued.
Key valuation signals for TPE:6936:
Debt-to-EBITDA: 0.08 (92% below median its 10-year median of 0.96)
GF Value™: NT$39.28 vs. price of NT$32.30 (17.8% below fair value)
Industry Position: 96.2% below the Consumer Packaged Goods median (#110 of 1554)
No single metric tells the full story. See the TPE:6936 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vetnostrum Animal Health Co Ltd is mainly engaged in importing, manufacturing, and selling pharmaceuticals and nutrition supplements for animals, feed additives, and feed. It derives a majority of its revenue from the sale of animal pharmaceuticals, medicated feed additives, and feeds and the rendering of drug testing services. Geographically, the company derives maximum revenue from Taiwan, followed by the USA, Malaysia, and other countries.
69GF Score
Get the complete analysis for TPE:6936
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6936 has been successfully added to your 
